Understanding impulsivity in Parkinson's disease
Biomarkers of Impulsivity in Parkinson's Disease
This study is looking into why some people with Parkinson's disease might struggle with impulsive behaviors like gambling or overeating, especially how their medications might play a role, so we can find better ways to help improve their lives and support their families.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Minneapolis VA Medical Center NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11116831 on NIH RePORTER |
What this research studies
This research investigates the causes and effects of impulsivity in patients with Parkinson's disease, particularly focusing on impulse control disorders such as compulsive gambling and binge eating. It aims to explore how dopamine-replacement therapies contribute to these behaviors and the impact they have on patients' quality of life and their caregivers. By identifying the underlying biological markers associated with impulsivity, the research seeks to develop better treatment strategies that can help manage these complications effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease who experience impulsivity or impulse control disorders.
Not a fit: Patients with Parkinson's disease who do not exhibit impulsivity or related disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for managing impulsivity in Parkinson's disease, enhancing patients' quality of life.
How similar studies have performed: Previous research has indicated a link between dopamine therapies and impulsivity in Parkinson's disease, suggesting that this area of investigation is both relevant and necessary.
Where this research is happening
Minneapolis, United States
- Minneapolis VA Medical Center — Minneapolis, United States (Active)
Researchers
- Principal investigator: Pellizzer, Giuseppe — Minneapolis VA Medical Center
- Study coordinator: Pellizzer, Giuseppe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.